The anticipated weak mass-spec market has not stopped vendors from launching new instruments, which may pay off later in the year when spending from the economic stimulus package could hit instrument manufacturers.
The firm also said that it and NextGen Sciences have developed a protein biomarker assay method that can provide rapid, reproducible, quantitative measurement of protein expression in formalin-fixed, paraffin-embedded tissue.
The AB Sciex TOF/TOF 5800, which the companies said enables researchers to identify 30 percent more proteins and speed up the biomarker discovery process 10-fold, follows platform launches in the fall meant to put them back at the top of the mass-spec food chain.
CompuCyte, Children's Hospital Boston, US Senate, National Institutes of Health, Albert Einstein College of Medicine, Empire State Stem Cell Board, MDS, Caliper Life Sciences, CHDI, GlobalStem, ADMEcell, Advancell
The Houston-based startup plans to commercialize the reagents, called Lightning Terminators, for use with at least one existing sequencing platform. Long term, it wants to develop its own sequencing instrument for applications in personalized genomics.